10 Essential Tremor Clinical Trials in The Bronx, NY (2026)

Q: How do I join a clinical trial in The Bronx?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the The Bronx research site will contact you.

Recruiting Essential Tremor Studies in The Bronx

NCT06019624Recruiting

Fresh Takes!: An Evaluation of the Impact of Receiving Fresh Food Boxes

Fresh Takes! is a targeted food distribution and nutrition education program offered by Montefiore Bronx Health Collective, a Federally Qualified Health Center located in the South Bronx. The goal of ...

The Bronx, NYNA400 participantsMontefiore Medical Center

View Study Details

NCT06545331Recruiting

Study of XB010 in Subjects With Solid Tumors

This is a FIH study is to evaluate the safety, tolerability, PK, immunogenicity, and preliminary antitumor activity of XB010 as a single agent and in combination with pembrolizumab in subjects with lo...

The Bronx, NYPHASE1396 participantsExelixis

View Study Details

NCT05422911Recruiting

Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.

The investigators have used national VHA data to demonstrate real-world efficacy of abiraterone and enzalutamide in Veterans with mCRPC. In the real-world that is the VHA, the investigators have succe...

The Bronx, NYPHASE2192 participantsSun Pharmaceutical Industries Limited

View Study Details

NCT06217302Recruiting

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

Powerful new drugs that can prevent or delay end stage kidney disease (ESKD) - so called sodium-glucose cotransporter-2 inhibitors (SGLT2i) - are now available for patients with type 2 diabetes. Wheth...

The Bronx, NYPHASE3150 participantsAlessandro Doria

View Study Details

NCT06240728Recruiting

A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2

NPX887 is a human, antagonistic immunoglobulin G1 (IgG1) monoclonal antibody targeting B7-H7 (HHLA2) that may potentiate an anti-tumor immune response. The goal of this first-in-human study is to lear...

The Bronx, NYPHASE1144 participantsNextPoint Therapeutics, Inc.

View Study Details

NCT06236607Recruiting

Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes

Minoritized individuals with type 1 diabetes (T1D) have approximately 2% higher average A1c levels and twice the rate of hospitalizations, complications, and mortality as their white counterparts. How...

The Bronx, NYNA140 participantsBoston Medical Center

View Study Details

NCT07287150Recruiting

A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

This study will evaluate the efficacy and safety of the combination of inavolisib plus enzalutamide compared with physician's choice of alternative androgen receptor pathway inhibitor (ARPi) or doceta...

The Bronx, NYPHASE2100 participantsHoffmann-La Roche

View Study Details

NCT03540758Recruiting

Regulation of Endogenous Glucose Production by Central KATP Channels

Type 2 diabetes (T2D) affects the ability of the body to process glucose (sugar). Under fasting conditions, the liver is able to make sugar to maintain glucose levels in an important process called en...

The Bronx, NYPHASE2100 participantsAlbert Einstein College of Medicine

View Study Details

NCT05734313Recruiting

Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression

This project will evaluate a telemedicine-delivered, Unified Protocol for Cognitive-Behavioral Therapy (UP-CBT) enhanced with continuous glucose monitor (CGM) review to target anxiety and depressive s...

The Bronx, NYNA94 participantsAlbert Einstein College of Medicine

View Study Details

NCT06654037Recruiting

Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer

This phase I trial tests the safety, side effects, and best dose of abemaciclib in combination with 5-fluorouracil and how well it works in treating patients with colorectal cancer that has spread fro...

The Bronx, NYPHASE139 participantsNational Cancer Institute (NCI)

View Study Details

About Essential Tremor Clinical Trials in The Bronx

Essential tremor is one of the most common movement disorders, causing involuntary shaking, most often in the hands. It is different from Parkinson's disease, though the two can be confused. Treatment includes medications, focused ultrasound, and deep brain stimulation for severe cases.

There are currently 10 essential tremor clinical trials recruiting participants in The Bronx, NY. These studies are seeking a combined 1,755 participants. Research is being sponsored by Montefiore Medical Center, Exelixis, Sun Pharmaceutical Industries Limited and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Essential Tremor Clinical Trials in The Bronx — FAQ

Are there essential tremor clinical trials in The Bronx?

Yes, there are 10 essential tremor clinical trials currently recruiting in The Bronx, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in The Bronx?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the The Bronx research site will contact you about next steps.

Are clinical trials in The Bronx free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many The Bronx studies also compensate for your time and travel.

What essential tremor treatments are being tested?

The 10 active trials in The Bronx are testing new therapies including novel drugs, biologics, and treatment approaches for essential tremor.

Data updated August 31, 2026 from ClinicalTrials.gov